[Source: EV Living] – Phoenix Analysis & Design Technologies (PADT), an Arizona company, has received a National Cancer Institute (NCI) grant to develop a system to preserve tumor biopsies. Presently, clinicians have limited methods – such as monitoring tumor size – to evaluate the effectiveness of various therapies. PADT’s new device will allow researchers to preserve a snapshot of the tumor biology nearly as it exists “in-vivo” – inside the body. These snapshots, taken over time, will enable researchers to more directly evaluate treatment efficacy.
For more information: NCI Awards Grant for Development of System to Preserve Tumor Biopsies